IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: I. Luttichuys who wrote (447)	3/10/1997 6:45:00 PM
From: Don Cheng	of 1762

Hi Bennett, thanks for your reply. I was out-of-town in the past few days. I just want to give a reasonable explanation to these who had a question on the selling of IDPH from SKB recently. When they entered an agreement with IDEC to joinly develop CE9.1 in 1993, they were given the option to buy IDPH at certain amount a share for several million shares. Since they were also in the agreement with IDEC to sell these options at no more than certain amount per share, they have no intention to keep the stock when the stock price reach that level. The selling is to the benefit of SKB because they have no more benefit to keep these options. Anyway, I hope we will see it go beyond $30 and stay above the sea level within a few weeks. Keep in mind that Montgomery has a target of $52 in 12 months. Don

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next